Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection

Gastroenterology

Volumn 137, Issue 4, 2009, Pages 1289-1300

  Dunn, Claire ^a   Peppa, Dimitra ^a,b   Khanna, Pooja ^a,c   Nebbia, Gaia ^a   Jones, Meleri ^c   Brendish, Nathan ^a   Lascar, R Monica ^a,b   Brown, David ^c   Gilson, Richard J ^a,b   Tedder, Richard J ^a   Dusheiko, Geoffrey M ^c   Jacobs, Michael ^c   Klenerman, Paul ^d   Maini, Mala K ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Camden Primary Care Trust   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 29; ANTIVIRUS AGENT; IL10 PROTEIN, HUMAN; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ACUTE HEPATITIS; ADAPTIVE IMMUNITY; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INHIBITION KINETICS; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEROLOGY; T LYMPHOCYTE; VIREMIA; VIRUS LOAD; ACUTE DISEASE; BLOOD; HEPATITIS B VIRUS; IMMUNOLOGY; TIME; TREATMENT OUTCOME; VIROLOGY;

ACUTE DISEASE; ADULT; ANTIVIRAL AGENTS; CYTOKINES; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERLEUKIN-10; INTERLEUKIN-15; INTERLEUKINS; KILLER CELLS, NATURAL; MALE; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; VIREMIA;

EID: 70349435373     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.06.054     Document Type: Article

References (48)

1. Dunn C., Brunetto M., Reynolds G., et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204 (2007) 667-680
2. Maini M.K., Boni C., Lee C.K., et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191 (2000) 1269-1280
3. Reignat S., Webster G.J., Brown D., et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 195 (2002) 1089-1101
4. Boni C., Fisicaro P., Valdatta C., et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81 (2007) 4215-4225
5. Das A., Hoare M., Davies N., et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 205 (2008) 2111-2124
6. Lopes A.R., Kellam P., Das A., et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 118 (2008) 1835-1845
7. Muller U., Steinhoff U., Reis L.F., et al. Functional role of type I and type II interferons in antiviral defense. Science 264 (1994) 1918-1921
8. Andoniou C.E., van Dommelen S.L., Voigt V., et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 6 (2005) 1011-1019
9. Biron C.A. Interferons alpha and beta as immune regulators-a new look. Immunity 14 (2001) 661-664
10. Le Bon A., Durand V., Kamphuis E., et al. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 176 (2006) 4682-4689
11. McClary H., Koch R., Chisari F.V., et al. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 74 (2000) 2255-2264
12. Wieland S.F., Guidotti L.G., and Chisari F.V. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol 74 (2000) 4165-4173
13. Wieland S.F., Vega R.G., Muller R., et al. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol 77 (2003) 1227-1236
14. Robek M.D., Boyd B.S., and Chisari F.V. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 79 (2005) 3851-3854
15. Sommereyns C., Paul S., Staeheli P., et al. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4 (2008) e1000017
16. Kakimi K., Guidotti L.G., Koezuka Y., et al. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192 (2000) 921-930
17. Wieland S., Thimme R., Purcell R.H., et al. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101 (2004) 6669-6674
18. Wieland S.F., and Chisari F.V. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79 (2005) 9369-9380
19. Guidotti L.G., Rochford R., Chung J., et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 284 (1999) 825-829
20. Webster G.J., Reignat S., Maini M.K., et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32 (2000) 1117-1124
21. Thimme R., Wieland S., Steiger C., et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77 (2003) 68-76
22. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169 (2002) 4279-4287
23. Santini S.M., Lapenta C., Logozzi M., et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 191 (2000) 1777-1788
24. Moore K.W., de Waal Malefyt R., Coffman R.L., et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
25. McMahon B.J., Alward W.L., Hall D.B., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 (1985) 599-603
26. Fisicaro P., Valdatta C., Boni C., et al. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58 (2009) 974-982
27. Stacey A.R., Norris P.J., Qin L., et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83 (2009) 3719-3733
28. Guidotti L.G., and Chisari F.V. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1 (2006) 23-61
29. Katze M.G., He Y., and Gale Jr. M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2 (2002) 675-687
30. Duramad O., Fearon K.L., Chan J.H., et al. IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences. Blood 102 (2003) 4487-4492
31. Dolganiuc A., Chang S., Kodys K., et al. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J Immunol 177 (2006) 6758-6768
32. Tu Z., Bozorgzadeh A., Pierce R.H., et al. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med 205 (2008) 233-244
33. Biswas P.S., Pedicord V., Ploss A., et al. Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. J Immunol 179 (2007) 4520-4528
34. Zhang Z., Zhang J.Y., Wherry E.J., et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134 (2008) 1938-1949 1949 e1-3
35. Maini M.K., Boni C., Ogg G.S., et al. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 117 (1999) 1386-1396
36. Abel M., Sene D., Pol S., et al. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44 (2006) 1607-1616
37. Kaplan D.E., Ikeda F., Li Y., et al. Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J Hepatol 48 (2008) 903-913
38. Sun J., Madan R., Karp C.L., et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15 (2009) 277-284
39. Brockman M.A., Kwon D.S., Tighe D.P., et al. IL-10 is upregulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114 (2009) 346-356
40. Bertoletti A., and Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 38 (2003) 4-13
41. Guy C.S., Mulrooney-Cousins P.M., Churchill N.D., et al. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol 82 (2008) 8579-8591
42. Le Bon A., Etchart N., Rossmann C., et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4 (2003) 1009-1015
43. Hahm B., Trifilo M.J., Zuniga E.I., et al. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22 (2005) 247-257
44. Bahl K., Kim S.K., Calcagno C., et al. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol 176 (2006) 4284-4295
45. Robbins S.H., Bessou G., Cornillon A., et al. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 3 (2007) e123
46. Urbani S., Boni C., Amadei B., et al. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection. Hepatology 41 (2005) 826-831
47. Brooks D.G., Trifilo M.J., Edelmann K.H., et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12 (2006) 1301-1309
48. Ejrnaes M., Filippi C.M., Martinic M.M., et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203 (2006) 2461-2472